Figure 2
From: Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer
Comparison of Serum MIF amounts determined by different ELISA conditions. A subset of random serum samples were from pulled from our serum bank from patients with no documented diagnosis of prostate cancer (n = 5) and from patients with CaP (n = 5). The serum MIF amounts were determined in parallel using either a milk based serum blocking/diluent solution or phosphate buffered saline pH 7.4 with 1% bovine serum albumin. Data are expressed as median ± interquartile range, ** = p < 0.01, when compared to Milk normal serum samples.